Abbott Laboratories
ABT · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $42 | $40 | $44 | $43 |
| % Growth | 4.6% | -8.1% | 1.3% | – |
| Cost of Goods Sold | $21 | $20 | $21 | $20 |
| Gross Profit | $21 | $20 | $22 | $23 |
| % Margin | 50.8% | 50% | 51.1% | 53.9% |
| R&D Expenses | $3 | $3 | $3 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12 | $11 | $11 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $14 | $14 | $14 |
| Operating Income | $7 | $6 | $8 | $9 |
| % Margin | 16.3% | 16% | 19.2% | 21.4% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$1 |
| Pre-Tax Income | $7 | $7 | $8 | $8 |
| Tax Expense | -$6 | $1 | $1 | $1 |
| Net Income | $13 | $6 | $7 | $7 |
| % Margin | 31.9% | 14.3% | 15.9% | 16.4% |
| EPS | 7.67 | 3.3 | 3.94 | 3.97 |
| % Growth | 132.4% | -16.2% | -0.8% | – |
| EPS Diluted | 7.64 | 3.27 | 3.91 | 3.94 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $3 | $4 |
| EBITDA | $11 | $11 | $12 | $12 |
| % Margin | 25.8% | 26.4% | 27.2% | 28.2% |